Explore By Subject Area   

Immuno-Oncology 360°

Date: Mar 24, 2025 - Mar 26, 2025

Location: Boston, MA

​​​
11th Annual:
Latest Advancements and Data in Immuno-Oncology

Hear directly from science and business stakeholders on the latest data impacting IO to fight a wider range of cancers.

image placeholder

IO360° Delivers 4 Key Benefits

1. Delivering a 360° IO Community
Build faster and more impactful collaborations with researchers, clinicians, biopharma leaders, investors and policymakers to advance cancer treatments

2. The Latest Data Driving Broader Impact
Hear directly from KOLs on the latest data to help advance and improve outcomes for more patients across a wider range of cancers
​​​​​
3. 360° Future-Focused Agenda
Stay ahead of the curve through 100+ multi-dimensional talks covering preclinical research, translational science, clinical development, operational strategies, cell therapy and business advancements

4. 10+ Hours of Networking Opportunities
Meet with key stakeholders in biopharma, academia, investors and regulatory through 1:1 meetings and scheduled functions
​​​​​​​

2025 Key Topics

  Biomarkers/Assay Development 

Business and Investing Aspects

Discovery/Preclinical

Autoimmune Disease & IO

ADCs & IO

IO Combinations

Translational Science

Imaging Advancements

Cell Therapy

Clinical Operations

Clinical Developments

Neoadjuvant/Adjuvant Therapy

New Tech in Transformational Biology

And More

2025 Keynote & VIP All-Star Line Up

image placeholder

First FDA- Approved TCR Therapy for Solid Tumors
Dr Elliot Norry
Adaptimmune

image placeholder

Evolution and Future Directions in Cell Therapy
Dr Crystal Mackall
Stanford University

image placeholder

Investments & Adopting to IO Market Dynamics
Dr Arie Belldegrun
Allogene

image placeholder

CAR-T in Autoimmune Diseases
Dr Georg Schett
FAU Erlangen-Nürnberg

image placeholder

Designing Best-in-Class ADCs in IO
Dr Deepa Pakianathan
Delphi Ventures / Stealth Oncology Company

image placeholder

Strategic Innovations & Industry Trends
Dr Andrew Baum
Pfizer

Translational Science & Clinical Development Trailblazers

Dr Jonathan Rosenberg
​​​​​​​MSKCC

Dr Alexander Eggermont
Princess Máxima Center for Pediatric Oncology

Dr Nina Shah
AstraZeneca

Dr Charles Drake
J&J Innovative Medicine

Dr Delfi Krishna
Immatics Biotechnologies

Dr Olivier Rixe
Daiichi Sankyo

Dr Johanna Bennell
Roche

Dr Gregory Sawyer
Moffitt Cancer Center

Dr Naiyer Rizvi
Synthekine

Dr Rosanna Ricafort
BMS

Transformational Biology Experts

image placeholder

Dr William Hawkins
MUSC Hollings Cancer Center

image placeholder

Dr Dushen Chetty
Novartis

image placeholder

Dr Raluca Verona
AbbVie

image placeholder

Dr Kazusa Ishii
NCI

Investment and Business Development Pioneers

Rajiv Kaul
Fidelity Investments

Rakhshita Dhar
Leaps by Bayer

Dr Carl Gordon
​​​​​​​OrbiMed Advisors, LLC

Kallie Dirks
Morgan Stanley

Dr Emmett Schmidt
Merck

Innovators in IO Biotech

Dr Birgit Schultes
Intellia Therapeutics

Dr Priti Hegde
Kite Pharma

Dr Theresa LaVallee
Coherus BioSciences

Dr Roy Baynes
Eikon Therapeutics

Dr Ruben Rodriguez
cTRL Therapeutics

Clinical Operations Leadership

Andy Lee
Merck

Sarah White
Brigham and Women’s Hospital

Marta Arias-Salgado
Merck

Dr Michael Ku
Pfizer

Luisa Freitas Dos Santos
GSK

Networking and Business Opportunities

Partnering/One-on-One Meetings:

​​​​​​​ • Dedicated partnering tables to connect with fellow industry professionals, investors and KOLs
• Partnering tool to schedule partnering meetings
• Meeting times occur throughout all breaks, lunches and receptions
• Set up multiple meetings per day
• Search other attendee profiles
• Send private message to other attendees
• Dedicated partnering help desk

Scheduled Networking:

IO360° networking opportunities take place throughout the entire event including:
​​​​​​​
• Scheduled morning and afternoon breaks
• Lunches
• Reception
• Access to the Exhibit hall
• Early evening organized historical walks of downtown Brooklyn​​​​​​​

2025 Event Features

image placeholder
image placeholder
image placeholder
image placeholder

Who Attends

Companies Attending:

• AbbVie
• Abingworth
• Amgen
• Astellas Pharma
• AstraZeneca
• Avidity Partners
• Bayer Oncology
• BioNTech
• BMS
• Boehringer Ingelheim​​​​​​​
• City of Hope

• Daichii-Sankyo
• Fred Hutchinson Cancer Center
• Invus Group
• Janssen
• Kite Pharma
• Memorial Sloan Kettering Cancer Center​​​​​​​
• Merck
• Moderna
• Morgan Stanley

• Mount Sinai
• 
MPM BioImpact
• NCI
• Novartis
• OrbiMed
​​​​​​​• RA Capital
• Regeneron
​​​​​​​• Stanford University
• Stifel
​​​​​​​• Takeda
• And More!

"By bringing together groups such as scientists, investors, and experts in clinical trial design and logistics, it creates a forum where there's quite a lot of folks ​​​​​​​participating who are not traditionally talking to one another on a daily basis.- Dr Roy Baynes, Eikon Therapeutics​​​​​​​

Dr Kristen Hege Looks Back at Lessons Learned from a Career in CAR-T Therapy

Taking Lessons from the Last Decade of IO to Develop the Next Wave of Therapeutics

Dr Roy Baynes on Strategy Development for Keytruda

2025 Sponsors

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.